|
|
|
|
| LEADER |
03795nam a2200781 4500 |
| 001 |
ocn867001315 |
| 003 |
OCoLC |
| 005 |
20170124070006.4 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
131230s2014 enk ob 001 0 eng |
| 010 |
|
|
|a 2013051083
|
| 040 |
|
|
|a DLC
|b eng
|e rda
|e pn
|c DLC
|d YDX
|d N$T
|d IDEBK
|d E7B
|d DG1
|d CUI
|d YDXCP
|d OCLCF
|d MMU
|d RIV
|d COO
|d EBLCP
|d OCLCQ
|d CUS
|d OCLCO
|d DEBBG
|d LOA
|d GrThAP
|
| 019 |
|
|
|a 960200409
|a 961571642
|a 962665481
|
| 020 |
|
|
|a 9781118697894
|q (ePub)
|
| 020 |
|
|
|a 1118697898
|q (ePub)
|
| 020 |
|
|
|a 9781118697917
|q (Adobe PDF)
|
| 020 |
|
|
|a 111869791X
|q (Adobe PDF)
|
| 020 |
|
|
|a 9781118697191
|q (electronic bk.)
|
| 020 |
|
|
|a 1118697197
|q (electronic bk.)
|
| 020 |
|
|
|a 1118488520
|
| 020 |
|
|
|a 9781118488522
|
| 020 |
|
|
|z 9781118488522
|q (cloth)
|
| 029 |
1 |
|
|a AU@
|b 000052346359
|
| 029 |
1 |
|
|a CHBIS
|b 010259674
|
| 029 |
1 |
|
|a CHVBK
|b 325942749
|
| 029 |
1 |
|
|a NLGGC
|b 375338896
|
| 029 |
1 |
|
|a NZ1
|b 15581323
|
| 029 |
1 |
|
|a NZ1
|b 15906851
|
| 029 |
1 |
|
|a DEBBG
|b BV043396449
|
| 029 |
1 |
|
|a AU@
|b 000059223969
|
| 035 |
|
|
|a (OCoLC)867001315
|z (OCoLC)960200409
|z (OCoLC)961571642
|z (OCoLC)962665481
|
| 042 |
|
|
|a pcc
|
| 050 |
0 |
0 |
|a QP624.75.D77
|
| 072 |
|
7 |
|a MED
|x 075000
|2 bisacsh
|
| 072 |
|
7 |
|a SCI
|x 036000
|2 bisacsh
|
| 082 |
0 |
0 |
|a 612/.01524
|2 23
|
| 049 |
|
|
|a MAIN
|
| 245 |
0 |
0 |
|a Ligand design in medicinal inorganic chemistry /
|c editor, Tim Storr.
|
| 264 |
|
1 |
|a Chichester, West Sussex :
|b John Wiley & Sons Inc.,
|c 2014.
|
| 300 |
|
|
|a 1 online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
0 |
|
|a Print version record and CIP data provided by publisher.
|
| 505 |
0 |
|
|a Introduction to ligand design in medicinal inorganic chemistry -- Platinum-based anticancer agents -- Coordination chemistry and ligand design in the development of metal based radiopharmaceuticals -- Ligand design in D-block optical imaging agents and sensors -- Luminescent lanthanoid probes -- Metal complexes of carbohydrate-targeted ligands in medicinal inorganic chemistry -- Design of Schiff base-derived ligands: applications in therapeutics and medical diagnosis -- Metal-based antimalarial agents -- Therapeutic gold compounds -- Ligand design to target and modulate metal-protein interactions in neurodegenerative diseases -- Rational design of copper and iron chelators to treat Wilson's disease and hemochromatosis -- MRI contrast agents -- Photoactivatable metal complexes and their use in biology and medicine -- Metalloprotein inhibitors -- Ruthenium anticancer compounds with biologically-derived ligands.
|
| 650 |
|
0 |
|a DNA-drug interactions.
|
| 650 |
|
0 |
|a Ligand binding (Biochemistry)
|
| 650 |
|
0 |
|a Drugs
|x Design.
|
| 650 |
|
0 |
|a Pharmaceutical chemistry.
|
| 650 |
0 |
4 |
|a ADN.
|
| 650 |
0 |
4 |
|a Medicaments
|x Disseny.
|
| 650 |
0 |
4 |
|a Lligands (Bioquímica)
|
| 650 |
0 |
4 |
|a Química farmacèutica.
|
| 650 |
|
7 |
|a MEDICAL
|x Physiology.
|2 bisacsh
|
| 650 |
|
7 |
|a SCIENCE
|x Life Sciences
|x Human Anatomy & Physiology.
|2 bisacsh
|
| 650 |
|
7 |
|a DNA-drug interactions.
|2 fast
|0 (OCoLC)fst00886614
|
| 650 |
|
7 |
|a Drugs
|x Design.
|2 fast
|0 (OCoLC)fst00898790
|
| 650 |
|
7 |
|a Ligand binding (Biochemistry)
|2 fast
|0 (OCoLC)fst00998460
|
| 650 |
|
7 |
|a Pharmaceutical chemistry.
|2 fast
|0 (OCoLC)fst01060115
|
| 655 |
|
4 |
|a Llibres electrònics.
|
| 655 |
|
4 |
|a Electronic books.
|
| 655 |
|
0 |
|a Electronic books.
|
| 700 |
1 |
|
|a Storr, Tim,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t Ligand design in medicinal inorganic chemistry.
|d Chichester, West Sussex : John Wiley & Sons Inc., 2014
|z 9781118488522
|w (DLC) 2013049102
|
| 856 |
4 |
0 |
|u https://doi.org/10.1002/9781118697191
|z Full Text via HEAL-Link
|
| 994 |
|
|
|a 92
|b DG1
|
